Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients
NCT06253078Phase 4Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Apr 2024
- Primary completion
- Feb 2025
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of ciprofol, sponsored by Zhejiang Cancer Hospital. Started Apr 2024; status: completed.
02
Drugs
ciprofol
Beyond the preview
Go deeper on NCT06253078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06253078.